The role of neuropsychological mechanisms in implementation intentions to reduce alcohol consumption among heavy drinkers: a randomized trial

Journal of Behavioral Medicine
Elly McGrathChristopher J Armitage

Abstract

Implementation intention formation, which involves identifying triggers and linking them with coping strategies, has proven effective at reducing alcohol consumption in general populations. For the first time, the present study tested the ability of implementation intentions to reduce alcohol consumption among heavy drinkers and to explore potential neuropsychological mechanisms. At baseline, participants were randomized to form implementation intentions or to an active control group. There was a 5.7 unit (1 unit = 10 ml or 8 g ethanol) per week reduction ([95%CI 0.15, 11.19], p = 0.048) in alcohol consumption at 1 month follow-up among participants who formed implementation intentions, which was significantly more than controls F(1, 91) = 3.95, p = 0.048, a medium effect size (d = 0.47, Cohen, 1992). No significant differences in performance on the neuropsychological tasks were found between groups. The present study demonstrates for the first time that implementation intentions reduce alcohol consumption among heavy drinkers.

References

Oct 1, 1974·The American Journal of Psychiatry·D MayfieldP Hall
Apr 30, 1999·Journal of the Experimental Analysis of Behavior·J B RichardsH de Wit
Oct 16, 2001·Journal of the Experimental Analysis of Behavior·J MyersonM Warusawitharana
Apr 1, 2006·The British Journal of Social Psychology·Falko F SniehottaRalf Schwarzer
Oct 26, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Vered MurgraffMark McDermott
Feb 21, 2007·Addiction·Matt FieldAndrew Goudie
Jul 21, 2007·Journal of Behavior Therapy and Experimental Psychiatry·Matt FieldRobert Child
Dec 22, 2007·The British Journal of Social Psychology·Thomas L Webb, Paschal Sheeran
May 16, 2008·Drug and Alcohol Dependence·Matt Field, W Miles Cox
Oct 1, 2008·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Christopher J Armitage
Oct 15, 2008·The British Journal of Social Psychology·Thomas L WebbAleksandra Luszczynska
Sep 16, 2009·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Christopher J Armitage
Dec 17, 2009·Journal of Psychopharmacology·María José Fernández-SerranoAntonio Verdejo-García
Sep 15, 2010·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Mark Conner, Andrea R Higgins
Mar 5, 2011·Psychopharmacology·James MacKillopMarcus R Munafò
May 4, 2011·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Matt FieldJan De Houwer
Sep 8, 2011·Alcoholism, Clinical and Experimental Research·Helen BarkbyMatt Field
Jan 19, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Madelynne A Arden, Christopher J Armitage
Jul 31, 2012·Journal of Applied Behavior Analysis·Derek D ReedAdam T Brewer
Sep 1, 2012·The International Journal of Behavioral Nutrition and Physical Activity·Benjamin GardnerGert-Jan de Bruijn
Oct 12, 2012·Prevention Science : the Official Journal of the Society for Prevention Research·Christopher J Armitage, Madelynne A Arden
Nov 16, 2013·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Amy O'DonnellEileen Kaner
Mar 5, 2014·Applied Psychology. Health and Well-being·Martin S Hagger, Aleksandra Luszczynska
Sep 15, 2014·Addictive Behaviors·Reinout W WiersW Miles Cox
Sep 23, 2014·Addictive Behaviors·Madelon E van Hemel-RuiterReinout W Wiers
Apr 8, 2016·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Christopher J Armitage
Oct 17, 2017·Behavior Therapy·Tracy Epton, Christopher J Armitage
Mar 24, 2018·Drug and Alcohol Dependence·Carina CarbiaFrancisco Caamaño-Isorna
May 22, 2018·Experimental and Clinical Psychopharmacology·Alison LoobyTiffany D Russell

❮ Previous
Next ❯

Clinical Trials Mentioned

ISRCTN14874035

Software Mentioned

PsychoPy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.